Tag: REG

Invitation to attend Systemair AB’s (publ) Annual General Meeting 2025

SKINNSKATTEBERG, Sweden, July 24, 2025 /PRNewswire/ -- Shareholders in Systemair AB (publ), reg. no. 556160-4108 ("Systemair" or the "Company") are hereby invited to attend the Company's...

ADECOAGRO S.A. PRICES INTERNATIONAL 144A/REG S OFFERING OF ITS 7.500% SENIOR NOTES DUE 2032

LUXEMBOURG, July 23, 2025 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company") today announced the pricing of U.S.$500,000,000 aggregate principal amount of...

Nikon Z6III Mirrorless Camera Now Featuring 5 Star Customer Ratings & Instant $300 Savings at B&H

Capture Every Moment with Precision—The Nikon Z6III Mirrorless Camera, Now at a $300 Savings and Praised by Customers NEW YORK, July 23, 2025 /PRNewswire/ --...

Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The application screening acceptance by the Directorate confirms that the New Drug Submission is complete and begins a standard review procedure, potentially supporting approval of the vaccine in the first half of 2026.

Bavarian Nordics ansøgning om markedsføringstilladelse for chikungunyavaccinen er blevet accepteret til gennemgang af de canadiske lægemiddelmyndigheder

KØBENHAVN, Danmark, 22. juli 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at de canadiske lægemiddelmyndigheder, Health Canada, har accepteret selskabets ansøgning om markedsføringstilladelse for den virus-lignende partikel (VLP)-baserede, enkelt-dosis chikungunyavaccinekandidat, CHIKV VLP, til forebyggelse af sygdom forårsaget af chikungunyavirus hos personer på 12 år og ældre. Dermed starter myndighedernes standardgennemgang, hvilket potentielt understøtter godkendelse af vaccinen i første halvår 2026.

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 21, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, underscoring strong demand within China's...

Kaldalón hf.: Publication of Base Prospectus

Kaldalón hf., reg. no. 490617-1320, Köllunarklettsvegur 1, 104 Reykjavík, Iceland, has published a base prospectus in connection with the company's ISK 40,000,000,000 debt issuance programme for bonds and bills. The base prospectus, dated 18 July 2025, has been approved by the Financial Supervisory Authority of the Central Bank of Iceland.

Flex Announces Date for First Quarter Fiscal 2026 Earnings Call

AUSTIN, Texas, July 9, 2025 /PRNewswire/ -- Flex (NASDAQ: FLEX) will announce its first quarter fiscal 2026 financial results before the market opens on...

Ormat Technologies, Inc. to Host Conference Call Announcing Second Quarter 2025 Financial Results

RENO, Nev., July 07, 2025 (GLOBE NEWSWIRE) -- Ormat Technologies Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company, today announced that it plans to publish its second quarter financial results in a press release that will be issued on Wednesday, August 6, 2025, after the market closes. In conjunction with this report, the Company has scheduled a conference call to discuss the results at 10:00 a.m. ET on Thursday, August 7, 2025.

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/...

Regency Centers Invites You to Join Its Second Quarter 2025 Earnings Conference Call

JACKSONVILLE, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its second quarter 2025 earnings results on Tuesday, July 29, 2025, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Wednesday, July 30, 2025, at 11:00 a.m. ET.

Tamron Announces 16-30mm F2.8 Wide-Angle Zoom, Tamron Completes G2 Lens Trinity with the new 16-30mm Lens – Preorder and More Info at B&H Photo

Tamron's third premium G2 lens, the 16-30mm f/2.8 wide-angle zoom lens, offers premium optical design and is ideal for travel, landscape, astrophotography, and more. NEW...

36/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities

Company announcement no. 36 / 2025
Schindellegi, Switzerland – 25 June 2025

NCIG Announces Pricing Terms for Cash Tender Offers for Certain Outstanding Debt Securities

NEWCASTLE, NEW SOUTH WALES, Australia, June 24, 2025 /PRNewswire/ -- Newcastle Coal Infrastructure Group Pty Ltd (the "Company"), a direct wholly-owned subsidiary of NCIG Holdings...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsREG

InventHelp Inventor Develops New Itch Relief Product (CNH-6076)

Cabinetworks Group appoints Danielle Mikesell as new chief commercial officer

GENESIS, U.S. SOCCER FOUNDATION, AND MLS PLAYERS ASSOCIATION SUPPORT YOUTH SPORTS WITH NEW MINI-PITCH IN ILLINOIS